Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
#6. Emerging Guide Wire<br />
Techknowledge in PTCA<br />
Co-Sponsored by Abbott Vascular<br />
Coronary Arena, Level 1<br />
Moderators: Naoto Inoue<br />
Chris Kwok Yiu Wong<br />
7:00 AM<br />
7:10 AM<br />
7:30 AM<br />
7:50 AM<br />
8:10 AM<br />
#7. VH-IVUS: Clinical Application,<br />
Experience, and Future Utility<br />
Co-sponsored by Volcano(BT+)<br />
Room 4-1(Pine Room), Level 4<br />
Moderators: Gary S. Mintz<br />
Barry D. Rutherford<br />
7:00 AM<br />
7:05 AM<br />
7:15 AM<br />
7:35AM<br />
7:50 AM<br />
8:05 AM<br />
8:10 AM<br />
Breakfast Will Be Served<br />
Introcution to HT Advance &<br />
Whisper ES<br />
Young-Guk Ko<br />
Case Reports on Successful<br />
Uses of HT Advance<br />
Chris Kwok Yiu Wong<br />
Advanced GW Techniques<br />
(Bifurcation Lesions)<br />
Hweung Kon Hwang<br />
Adjourn<br />
Welcome Address<br />
Gary S. Mintz<br />
Virtual Histology: From<br />
Thoery to Current Limitations<br />
William Kongto Hau<br />
Virtual Histology: Clinical<br />
Update<br />
Gary S. Mintz<br />
Virtual Histology: Clinical<br />
Case Examples<br />
Barry D. Rutherford<br />
Use of VH-Findings as<br />
Surrogate Marker for Anti-<br />
Atherosclerotic Drug<br />
Duk-Woo Park<br />
Q & A<br />
Adjourn<br />
#8. Cypher Summit<br />
Co-sponsored by Johnson & Johnson Medical Korea<br />
Room 4-2(Oak Room), Level 4<br />
Moderators: Seong-Wook Park<br />
Seung-Jung Park<br />
7:00 AM<br />
7:05 AM<br />
7:15 AM<br />
7:35 AM<br />
7:45 AM<br />
8:05 AM<br />
Opening<br />
Seung-Jung Park<br />
“ZEST” Trial<br />
Seung-Jung Park<br />
Group Discussion<br />
“Diabetes-DM” Trial and Clinical<br />
performance of different DES in<br />
DM<br />
Seong-Wook Park<br />
Group Discussion<br />
Wrap Up and Adjourn<br />
Thursday, April 23, 2009<br />
Lunchtime Activities<br />
12:30 PM-1:30 PM<br />
#1. Strategic Approaches to Obtain<br />
Better and Earlier CV Outcome<br />
Co-sponsored by Pfizer Pharmaceutical Korea Ltd.<br />
Coronary Arena, Level 1<br />
Moderator: Jeong Euy Park<br />
12:30 PM<br />
12:35 PM<br />
1:05 PM<br />
1:20 PM<br />
Opening Address<br />
Jeong Euy Park<br />
Strategic Approaches to Obtain<br />
Better and Earlier CV Outcome<br />
Weon Kim<br />
Q & A<br />
Adjourn<br />
#2. What's the Ideal Treatment with<br />
Antiplatelet?<br />
Co-sponsored by Johnson & Johnson Medical Korea<br />
Endovascular Arena, Level 1<br />
Moderator: Junghan Yoon<br />
12:30 PM<br />
12:35 PM<br />
12:55 PM<br />
1:15 PM<br />
1:30 PM<br />
Welcome Address<br />
Junghan Yoon<br />
Anti-platelet Therapies in<br />
Cardiovascular Disease: From<br />
Stable CAD to ACS and Afib<br />
Roxana Mehran<br />
What Is the Optimal Duration of<br />
DAPT Following DES Treatment?<br />
David E. Kandzari<br />
Q & A<br />
Adjourn<br />
Angioplasty Summit-TCT Asia Pacific 2009 27 28
Change language